» Articles » PMID: 39074884

Epidemiology, Clinical Profiles, and Antimicrobial Susceptibility of Infections: Insights from a Tertiary Care Hospital in Saudi Arabia

Abstract

Objectives: To investigate the incidence rate, clinical characteristics across different age groups, antimicrobial susceptibility, and outcomes of () infections.

Methods: A retrospective analysis was carried out to include 66 cases with confirmed cultures from sterile samples between January 2014 and June 2022 at King Faisal Specialist Hospital and Research Centre in Riyadh, Saudi Arabia.

Results: A total of 66 cases were identified, with an incidence rate of 0.3 per 1000 admissions. Most cases were hospital-acquired (80.3%), primarily in critical care areas. All patients had underlying diseases, with respiratory (40.9%) and cardiovascular (39.4%) diseases being the most common. Minocycline showed the highest susceptibility (96.0%), followed by trimethoprim/sulfamethoxazole (77.0%), whereas tobramycin and colistin were fully resistant. The in-hospital mortality rate was 34.8%, whereas the 28-day mortality rate was 22.7%. Clinical characteristics across age groups showed a higher prevalence of cardiovascular disease in pediatrics than in adults, whereas exposure to mechanical ventilation, immunosuppressive therapy, previous infection, anemia, and in-hospital mortality were reported more frequently in adults (<0.05).

Conclusion: Our study provides valuable insights into infection in Saudi Arabia, emphasizing the importance of robust infection control measures. Incidence and mortality rates align with global trends. Variations in clinical characteristics across age groups highlight the importance of tailored treatments based on patient demographics and underlying comorbidities.

Citing Articles

Distinct relative abundances in pathogens detected in mechanically ventilated patients with suspected pneumonia in the intensive care unit at King Abdulaziz University Hospital.

Algethamy H, Bokhary D, Abushoshah I, Alalyani A, Baamer M, Attallah D Sci Rep. 2025; 15(1):3291.

PMID: 39865132 PMC: 11770149. DOI: 10.1038/s41598-025-88087-0.

References
1.
Gonzalez L, Vila A . Carbapenem resistance in Elizabethkingia meningoseptica is mediated by metallo-β-lactamase BlaB. Antimicrob Agents Chemother. 2012; 56(4):1686-92. PMC: 3318372. DOI: 10.1128/AAC.05835-11. View

2.
Lau S, Chow W, Foo C, Curreem S, Lo G, Teng J . Elizabethkingia anophelis bacteremia is associated with clinically significant infections and high mortality. Sci Rep. 2016; 6:26045. PMC: 4868968. DOI: 10.1038/srep26045. View

3.
Hsu M, Liao C, Huang Y, Liu C, Yang C, Kao K . Clinical features, antimicrobial susceptibilities, and outcomes of Elizabethkingia meningoseptica (Chryseobacterium meningosepticum) bacteremia at a medical center in Taiwan, 1999-2006. Eur J Clin Microbiol Infect Dis. 2011; 30(10):1271-8. DOI: 10.1007/s10096-011-1223-0. View

4.
Hu R, Zhang Q, Gu Z . Molecular diversity of chromosomal metallo-β-lactamase genes in Elizabethkingia genus. Int J Antimicrob Agents. 2020; 56(1):105978. DOI: 10.1016/j.ijantimicag.2020.105978. View

5.
Choi M, Kim M, Jeong S, Choi J, Lee I, Yong T . Risk Factors for Elizabethkingia Acquisition and Clinical Characteristics of Patients, South Korea. Emerg Infect Dis. 2018; 25(1):42-51. PMC: 6302585. DOI: 10.3201/eid2501.171985. View